» Articles » PMID: 1775200

Class III Antiarrhythmic Drugs (amiodarone, Bretylium and Sotalol) on Action Potentials and Membrane Currents in Rabbit Sino-atrial Node Preparations

Overview
Specialty Pharmacology
Date 1991 Dec 1
PMID 1775200
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Electrophysiological effects of class III antiarrhythmic drugs (amiodarone, bretylium and sotalol) were examined in spontaneously beating and voltage-clamped rabbit sino-atrial node preparations, using a two microelectrode technique. At 10(-6) mol/l these class III antiarrhythmic drugs prolonged the cycle length significantly, but did not affect the action potential duration. At high concentration (10(-4) mol/l), amiodarone and sotalol prolonged the action potential duration as well as the cycle length. Sotalol 10(-5) mol/l depolarized the maximum diastolic potential. Amiodarone 10(-4) mol/l and bretylium 10(-5) mol/l depressed the maximum rate of depolarization. At concentrations ranging from 10(-7) to 10(-4) mol/l, amiodarone induced dysrhythmia in 5 of 10 preparations and bretylium in 3 of 7 preparations, but sotalol in none of 5 preparations. In voltage-clamped sino-atrial node preparations, all the class III antiarrhythmic drugs decreased the slow inward current in a concentration-dependent manner. The steady-state outward and the hyperpolarization-activated inward currents were also reduced. Sotalol (10(-5) mol/l) decreased both the outward current and the hyperpolarization-activated inward current stronger than the slow inward current. In addition, amiodarone (3 x 10(-6) mol/l) depressed the inactivation curve for the slow inward current, but it did not shift the potential of half-maximum inactivation. The drugs also depressed the activation curve for the outward current in a concentration-dependent manner. However, the values of half-maximum activations were not influenced by these drugs as compared to control.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Electropharmacological effects of berberine on canine cardiac Purkinje fibres and ventricular muscle and atrial muscle of the rabbit.

Riccioppo Neto F Br J Pharmacol. 1993; 108(2):534-7.

PMID: 8448600 PMC: 1908004. DOI: 10.1111/j.1476-5381.1993.tb12836.x.


Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Fitton A, Sorkin E Drugs. 1993; 46(4):678-719.

PMID: 7506652 DOI: 10.2165/00003495-199346040-00007.

References
1.
Culling W, Penny W, Sheridan D . Effects of sotalol on arrhythmias and electrophysiology during myocardial ischaemia and reperfusion. Cardiovasc Res. 1984; 18(7):397-404. DOI: 10.1093/cvr/18.7.397. View

2.
Patterson E, Lucchesi B . Bretylium: a prototype for future development of antidysrhythmic agents. Am Heart J. 1983; 106(2):426-31. DOI: 10.1016/0002-8703(83)90225-9. View

3.
Mason J, Hondeghem L, KATZUNG B . Block of inactivated sodium channels and of depolarization-induced automaticity in guinea pig papillary muscle by amiodarone. Circ Res. 1984; 55(3):278-85. DOI: 10.1161/01.res.55.3.278. View

4.
Bennett D . Acute prolongation of myocardial refractoriness by sotalol. Br Heart J. 1982; 47(6):521-6. PMC: 481177. DOI: 10.1136/hrt.47.6.521. View

5.
Noma A, Irisawa H . A time- and voltage-dependent potassium current in the rabbit sinoatrial node cell. Pflugers Arch. 1976; 366(2-3):251-8. DOI: 10.1007/BF00585886. View